3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
10
Unknown
1
Terminated
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
5
Other hematologic neoplasm
1
Myeloid
1
Dermatologic
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Imatinib Mesylate
17
Cytarabine
13
Azacitidine
13
Cyclophosphamide
11
Decitabine
9
Dasatinib
9
Etoposide
8
nilotinib
7
Peripheral Blood Stem Cell Transplantation
7
Busulfan
7
Tacrolimus
6
Polymerase Chain Reaction
6
Idarubicin
6
Antilymphocyte Serum
6
fludarabine phosphate
5
Mycophenolic Acid
5
Melphalan
5
Blood Specimen Collection
5
ruxolitinib
4
pegaspargase
4
fludarabine
4
Whole-Body Irradiation
4
Radiotherapy
4
Methylprednisolone
4
Hydroxyurea
4
Filgrastim
4
ponatinib
3
Surveys and Questionnaires
3
Rituximab
3
Lenalidomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
peginterferon alfa-2a
×
Myeloid
×
Clear all
NCT02381379
2020-09-14
MSIT
Ministry of Health, Malaysia
Phase 3
Unknown
118 enrolled